Last updated on March 2019

Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ulcerative Colitis
  • Age: Between 18 - 99 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Suffering from ulcerative colitis
  • Nave from Adalimumab
  • Starting a treatment with adalimumab
  • Capable of and willing to grant authorization for use/disclosure of data collected
  • Able to read, understand, and complete patients questionnaires

Exclusion Criteria:

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.